Amphastar Pharmaceuticals Inc (AMPH)

Finanzdaten der Amphastar Pharmaceuticals Inc-Aktie (AMPH)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7.44%183.90	171.17	183.11	191.84	174.41
Cost Of Revenue	10.33%90.43	100.85	97.44	93.19	87.92
Gross Profit	32.92%93.47	70.32	85.67	98.65	86.49
	5.21%53.74	56.69	50.06	73.33	44.31
Research and Development	17.10%22.16	26.74	23.31	22.35	20.08
Operating Income/Loss	191.48%39.73	13.63	35.61	25.32	42.18
Nonoperating Income/Loss	66.88%-1.19	-3.58	-3.69	-3.81	-2.85
Income/Loss From Continuing Operations Before Tax	283.45%38.54	10.05	31.91	21.51	39.34
Income Tax Expense/Benefit	125.66%8.20	3.63	7.49	4.16	8.31
	372.71%30.35	6.42	24.43	17.35	31.03
Attributable To Parent	372.71%30.35	6.42	24.43	17.35	31.03
Basic Average Shares	3.70%43.64	45.32	-0.28	46.47	46.95
Diluted Average Shares	4.81%44.23	46.46	-0.35	47.68	48.13
Basic Earnings Per Share	392.86%0.69	0.14	0.53	0.38	0.66
Diluted Earnings Per Share	378.57%0.67	0.14	0.51	0.37	0.64